Exercise programmes in pregnancy raised activity and lowered several complications: a meta-analysis of 88 randomised trials (most at some concerns for bias) found more total activity (SMD 0.62, 95% CI 0.30-0.94), less gestational diabetes (RR 0.75, 0.63-0.88), fewer hypertensive disorders (RR 0.67, 0.54-0.83), fewer caesarean sections (RR 0.86, 0.80-0.93) and less gestational weight gain (SMD −0.28, −0.36 to −0.19), with no significant effect on sedentary time, prenatal depression, birthweight or preterm birth
Xiang and colleagues asked whether exercise interventions in pregnancy raise physical activity, which features of the interventions go with larger effects, and what they do to sedentary behaviour, maternal health and pregnancy outcomes.
They searched eight databases to 1 April 2026, included 88 randomised trials, judged most of them at some concerns for bias with RoB 2.0, and pooled with random-effects models. Exercise interventions increased total physical activity (SMD 0.62), moderate-to-vigorous activity (0.32), exercise activity (1.04) and step count (0.33).
They reduced gestational diabetes (RR 0.75), hypertensive disorders of pregnancy (RR 0.67), caesarean section (RR 0.86), total gestational weight gain (SMD −0.28), fasting glucose (SMD −0.67) and 2-hour post-meal glucose (SMD −0.48). They had no significant effect on sedentary behaviour, prenatal depression, birthweight or preterm birth.
Exploratory subgroups suggested larger activity effects with combined aerobic and strength training, individualised or unsupervised formats and mobile-health support. The authors conclude that exercise interventions appear to increase activity in pregnancy and may improve maternal health and pregnancy outcomes.
Participants
Protocol
Key Results
| Outcome (exercise vs control) | Effect (95% CI) |
|---|---|
| Total physical activity | SMD 0.62 (0.30 to 0.94) |
| Moderate-to-vigorous physical activity | SMD 0.32 (0.08 to 0.57) |
| Exercise activity | SMD 1.04 (0.63 to 1.46) |
| Step count | SMD 0.33 (0.12 to 0.55) |
| Gestational diabetes | RR 0.75 (0.63 to 0.88) |
| Hypertensive disorders of pregnancy | RR 0.67 (0.54 to 0.83) |
| Caesarean section | RR 0.86 (0.80 to 0.93) |
| Total gestational weight gain | SMD −0.28 (−0.36 to −0.19) |
| Fasting blood glucose | SMD −0.67 (−1.01 to −0.34) |
| 2-hour postprandial blood glucose | SMD −0.48 (−0.65 to −0.30) |
| Sedentary behaviour, prenatal depression, birthweight, preterm birth | no significant effect (estimates not in the abstract) |
Practical Application
Limitations
How this entry was checked and changed
a meta-analysis of randomised trials whose abstract reports its risk-of-bias appraisal and the result (most trials at some concerns, not mostly high risk), so the abstract-only cap does not apply; held at A- because heterogeneity, certainty grading and the number of trials per outcome are not in the abstract, how activity was measured is not stated, and the intervention-feature findings are exploratory subgroup splits; the glucose results are markers and stand one step lower (B+)